Mammary adipose tissue may contribute to breast cancer development and progression by altering neighboring epithelial cell behavior and phenotype through paracrine signaling. Dietary exposure to soy foods is associated with lower mammary tumor risk and reduced body weight and adiposity in humans and in rodent breast cancer models. Despite the suggested linkage between obesity and breast cancer, the local influence of bioactive dietary components on mammary adiposity for antitumor effects remains unknown. Herein, we report that post-weaning dietary exposure to soy protein isolate and its bioactive isoflavone genistein (GEN) lowered mammary adiposity and increased mammary tumor suppressor PTEN and E-cadherin expression in female mice, relative to control casein diet. To ascertain GEN's role in mammary adipose deposition that may affect underlying epithelial cell phenotype, we evaluated GEN's effects on SV40-immortalized mouse mammary stromal fibroblast-like (MSF) cells during differentiation into adipocytes. MSF cells cultured in a differentiation medium with 40 nM GEN showed reductions in mature adipocyte numbers, triglyceride accumulation, and Pparg (Pparg) and fatty acid synthase transcript levels. GEN inhibition of adipose differentiation was accompanied by increased estrogen receptor b (Erb (Esr2)) gene expression and was modestly recapitulated by ERb-selective agonist 2,3-bis-(4-hydroxyphenyl)-propionitrile (DPN). Reduction of Erb expression by siRNA targeting increased Pparg transcript levels and stromal fibroblast differentiation into mature adipocytes; the latter was reversed by GEN but not by DPN. Conditioned medium from GEN-treated adipocytes diminished anchorage-independent mammosphere formation of human MCF-7 breast cancer cells. Our results suggest a mechanistic pathway to support direct regulation of mammary adiposity by GEN for breast cancer prevention. 
Introduction
Obesity is a major health problem in the United States and globally (Fiegel et al. 2010 , Swinburn et al. 2011 . The rising trend in its incidence and prevalence (Parikh et al. 2007 ) warrants serious attention, given its linkage to increased risks for many chronic diseases (Calle & Kaaks 2004 , Flynn et al. 2006 including breast cancer, the second leading cause of cancer deaths among women (Ligibel 2011) . Obesity is an independent risk factor for the development of hormone receptor-positive breast cancer in postmenopausal women (Key et al. 2003) and of basal-like breast cancer in premenopausal African-American women (Millikan et al. 2007 , Rose et al. 2007 . The connection between obesity and breast cancer has been attributed in part to adipose tissue dysfunction characterized by ectopic fat deposition in abdomen and liver, leading to increased systemic inflammation, oxidative stress, and insulin resistance (Bastard et al. 2000 , Van Kruijsdijk et al. 2009 , Olefsky & Glass 2010 . In this regard, the pro-inflammatory cytokine interleukin-6, whose levels increase with body mass (Hoene & Weigert 2008) , is considered to constitute a viable marker for poor prognosis in breast cancer patients (Hong et al. 2007 ).
Similar to other adipose tissue depots, mammary adipose tissue actively secretes factors including chemokines and cytokines that likely exert paracrine effects on neighboring epithelial cells (Park et al. 2011) . However, it remains unclear to what extent BMI influences mammary adipose biology and how this relates to breast cancer risk. Recently, a positive association was found between BMI and breast adipocyte size (Morris et al. 2011) . Moreover, breast tissues of obese women (Morris et al. 2011) as well as mammary glands of genetically modified and dietinduced obese mice (Subbaramaiah et al. 2011) were shown to display subclinical inflammation characterized by increased P450 aromatase activity and enhanced NF-kB activity. As inflammation is a hallmark of cancer, the correlation of obesity with 'local' mammary adipocyte dysfunction may provide a rational basis for the increased risk and poor prognosis of breast cancer associated with obesity (Anderson & Neuhouser 2012) .
Epidemiological, clinical, and preclinical (animal) studies have provided ample evidence indicating that breast cancer development can be influenced by diet and lifestyle (Brennan et al. 2010 , Patterson et al. 2010 . High consumption of soy-rich foods containing genistein (GEN) is considered to partly underlie the lower breast cancer incidence in Asian women than in their western counterparts (Wu et al. 2008 , Hooper et al. 2010 . The antitumor effects of soy foods and bioactive GEN have been demonstrated in many rodent models of breast cancer (Jin & MacDonald 2002 , Su et al. 2007b , Verheus et al. 2007 , Wu et al. 2008 to occur through multiple mechanisms. These include tumor suppressor induction and oncogene downregulation (Dave et al. 2005 , Su et al. 2007a ), strong antioxidant activity through redox signaling (Djuric et al. 2001) , anti-inflammatory actions through inhibition of pro-inflammatory cytokine expression (Chan et al. 2009 , Hsu et al. 2010 , increased insulin sensitivity (Fu et al. 2012) , and anti-adipogenic capacity ). In the context of obesity, GEN has been shown to decrease body and fat pad weights in rodent models and in humans (Kim et al. 2006 , Orgaard & Jensen 2008 , Park et al. 2008 ) and inhibit adipogenesis (Kandulska et al. 1999 , Park et al. 2008 , Zhang et al. 2009 ) and lipid metabolism characterized by decreased expression of key lipogenic enzyme genes such as fatty acid synthase and malic enzyme 1 , Takahashi et al. 2009 ). Nevertheless, given that anatomically distinct fat depots exhibit dissimilar biological effects, expression patterns, and abundance of markers of adiposity (McTernan et al. 2002 , Shi et al. 2006 , Fain et al. 2008 , and as the majority of studies evaluating the effects of GEN were previously conducted on non-mammary adipose depots (Park et al. 2008 ), the exact function of GEN in mammary adipocytes as a direct conduit to influence normal and pathological mammary epithelial cell behavior is yet to be understood.
Our goals in this study were to determine whether GEN directly inhibits mammary adipogenesis and to evaluate the biological consequence of GEN-mediated adipogenic changes on the expansion of mammary cancer stem-like/progenitor cells. Dysregulation of the biology and function of these mammary epithelial subpopulations is widely considered to initiate breast cancer (Cho et al. 2008 , Visvader 2009 ). We here show that limited dietary exposure of mice beginning at post-weaning to soy protein isolate (SPI) and to GEN-fortified Casein (CAS) decreased mammary adipocyte cell size. Using a mouse mammary stromal fibroblastic cell line (MSF) that can differentiate into mature adipocytes under suitable culture conditions (Nakatani et al. 2010) , we further show that GEN inhibition of mammary adipogenesis is associated with induction of Erb (Esr2) expression and inhibition of Pparg (Pparg) and Fasn expression. Importantly, conditioned media from GEN-treated MSF cells showing reduced adipocyte differentiation blocked mammosphere formation, an accepted surrogate of tumorigenesis (Al-Hajj et al. 2003 , Cho et al. 2008 , in estrogen receptor (ERC) human breast cancer MCF-7 cells. Our results suggest that GEN inhibition of mammary adipocyte differentiation may alter cancer stem-like expansion, thus linking GEN's 'local' anti-adipogenic effects with potential antitumor actions for breast cancer prevention.
Materials and methods

Animals and diets
Animal experiments were carried out under protocols approved by the Institutional Animal Care and Use Committee, University of Arkansas for Medical Sciences. Mice (B6SJL/J; Jackson Laboratories, Bar Harbor, ME, USA) were housed in polycarbonate cages under conditions of 24 8C, 40% humidity, and a 12 h light:12 h darkness cycle. Dams were fed a semi-purified isocaloric, American Institute of Nutrition (AIN)-93G-based diet containing casein (New Zealand Milk Products, Santa Rosa, CA, USA) (designated CAS diet) as the sole protein source during pregnancy and lactation. At weaning (postnatal day (PND) 21), female pups were exposed to either CAS diet, AIN-93G-based diet containing SPI (Harlan Laboratories, Madison, WI, USA) as the sole protein source, or CAS diet with added GEN . Mice were allowed to consume food and water ad libitum. Mice were killed at PND 35, and for each mouse, the right mammary inguinal gland (#4) was fixed for histological analysis, while the left mammary inguinal gland was harvested for protein analysis by western blotting.
Histological analysis
To determine adipocyte cell size of mouse mammary glands, sections of the right inguinal (#4) mammary gland from PND 35 mice were stained with hematoxylin and eosin. Adipocyte areas were measured in two to three random fields per slide (w200-300 cells per field) from four individual mice per diet group, using Axiovision software (Carl Zeiss AG, Oberkochen, Germany), as described previously ).
Cell culture and induction of adipogenic differentiation
The mouse MSF cell line has been described previously (Nakatani et al. 2010) . Cells were propagated in DMEM (Invitrogen) supplemented with 10% FCS (Gibco) and 1% antibiotic-antimycotic solution (Gibco) in 10 cm dishes in an atmosphere of 5% CO 2 :95% air at 32 8C. Two days after confluence, cells were plated at a density of 5!10 4 cells/well (in six-well plates), transferred to a 39 8C incubator, and induced to differentiate into adipocytes using the propagation culture medium (above) supplemented with a cocktail containing 1 mg/ml hydrocortisone (Sigma Chemical Co.), 5 mg/ml insulin (Sigma), and 2.5 mg/ml troglitazone (Cayman Chemical, Ann Arbor, MI, USA). GEN (Sigma) dissolved in dimethylsulfoxide (DMSO; Sigma) was added at 40 nM or 2 mM final concentrations, while the ERb-selective agonist 2,3-bis-(4-hydroxyphenyl)-propionitrile (DPN; Sigma) in DMSO was used at a 50 nM final concentration. The medium was changed every 3 days, and on day 14, cells were collected and processed for various morphological and biochemical determinations (described below).
Oil Red O staining
Differentiated MSF cells grown in six-well plates were fixed with formalin and stained with 0.5% Oil Red O (Sigma). Stained adipocytes were identified in four microscopic fields/well (nZ4 wells/treatment group) using Axiovision software.
RNA preparation and quantitative real-time PCR (QPCR)
Total RNA was extracted from cells using Trizol reagent (Invitrogen) and reverse transcribed to cDNA using iScript cDNA synthesis kit (Bio-Rad Laboratories). Gene-specific primers (Supplementary Table 1 , see section on supplementary data given at the end of this article) were designed using Primer Express (Applied Biosystems) and synthesized by Integrated DNA Technologies, Inc.
(Coralville, IA, USA). QPCR was performed with SYBR Green Supermix (Bio-Rad Laboratories) and ABI Prism 7000 Detection System (Applied Biosystems), as described previously (Rahal & Simmen 2011) . The expression of each target mRNA was calibrated to a standard curve using pooled cDNA stocks and normalized to that of TATAbox binding protein (Tbp).
Transient transfection
MSF cells were propagated in culture medium in six-well plates as described above. Cells were serum-starved for 24 h overnight in phenol red-free medium supplemented with charcoal-stripped FCS (0.5% charcoal-stripped FCS; Gibco 
Triglyceride quantification assay
Triglyceride content of pre-adipose or adipose cells was quantified in cell extracts using a Biovision triglyceride assay kit (Biovision, Inc., Milpitas, CA, USA), following the manufacturer's instructions. Absorbance was read at 570 nm.
Western blot analysis
Whole cell extracts from mammary tissues and differentiated MSF cells were prepared and subjected to immunoblotting as described previously 
Cell viability assay
The human breast cancer cell line MCF-7 was purchased from American Type Tissue Collection (ATCC, Manassas, VA, USA) and propagated in DMEM supplemented with 10% FBS and 1% antibiotic-antimycotic solution at 37 8C. Cells were seeded in 96-well plates (5!10 3 cells/well) at the same temperature and cultured for 5 days with adipose-CM (1:1 vol:vol with culture medium; prepared above) from MSF treated with and without GEN (40 nM). Cell viability was evaluated using 3-(4,5-dimethylthiazole-2-yl)-2,5-biphenyl tetrazolium bromide assay (MTT; ATCC) following the manufacturer's protocol. Absorbance (570 nm) reflects the amount of formazan formed and was considered a direct measure of metabolically active cells in culture.
Mammosphere formation assay
Formation of mammospheres by MCF-7 cells followed previously described protocols (Montales et al. 2012) . Adipose-CM from MSFs treated or not with GEN (40 nM) was mixed with mammosphere-plating medium at 1:1 vol:vol ratio. Mammosphere-plating medium consisted of phenol red-free, serum-free minimal essential medium (MEM), supplemented with B27 (1!; Invitrogen), 20 ng/ml human basic fibroblast growth factor (Invitrogen), 20 ng/ml human epidermal growth factor (Invitrogen), 10 mg/ml heparin (Sigma), 1% antibioticantimycotic solution (Invitrogen), and 100 mg/ml gentamicin (Sigma). MCF-7 cells were cultured in the mixed medium in ultra-low attachment plates (Corning, Inc., Corning, NY, USA). Medium was refreshed after 3 days and the appearance of primary spheres (P1) was evaluated at day 5. To assess sphere numbers over the second passage (P2), P1 mammospheres were collected at day 5, dissociated with 0.05% trypsin (Invitrogen) into single cell suspensions, filtered using a 40 mm sieve, and replated in ultra-low attachment plates, with no additional treatments. P1 and P2 (collected at day 7) mammospheres were manually counted and sphere diameter was measured using Axiovision software.
To evaluate whether the inflammatory cytokine interleukin-6 secreted by mature adipocytes could reverse the direct effect of GEN on mammosphere-forming ability, MCF-7 cells were cultured in mammosphere-plating medium alone or with added IL6 (50 ng/ml; R&D Systems, Minneapolis, MN, USA) in the presence or absence of GEN (40 nM) for 5 days. P1 mammospheres were collected at day 5 and replated for a second passage (P2) with no additional treatments. P2 mammospheres were manually counted at 7 days post-plating.
Statistical analysis
All in vitro experiments were conducted at least two times, each in quadruplicate. Results are expressed as the means GS.E.M. Data were analyzed using Student's t-test or oneway ANOVA. Statistical significance of differences between groups was evaluated using SigmaStat version 3.5 for Windows. P%0.05 values were considered to be significant.
Results
Dietary SPI and GEN exposure reduce mammary adipocyte cell size and increase mammary expression of tumor suppressor genes Dietary exposure of female mice to SPI or GEN from PND 21 (weaning) to PND 35 did not affect body weights, relative to those of CAS diet-fed mice (data not shown). However, mice in the SPI and GEN diet groups showed smaller mammary fat cell sizes compared with those of mice in the CAS group. Representative pictures of H&E-stained sections of the mammary fat pads for each dietary group are shown in Fig. 1A . The majority (w90-95%) of mammary adipocytes in the SPI and GEN groups were in the size range of !500-1500 mm 2 while only 60% of the (Fig. 1C) . Similar increases in the expression levels of PTEN and E-cadherin proteins were observed in the GEN group, although these were not as robust as those found in the SPI group (Fig. 1D ).
MSF cells differentiate to mature adipocytes after hormonal induction
In this study, we utilized a recently characterized MSF cell line established from primary cultures of mouse mammary fat pads by infection with the temperature-sensitive SV40LT vector pMESVTS (Nakatani et al. 2010) . Unlike in the initial report wherein MSF cells were cultured in extracellular matrix, hormonal induction of MSF cells into adipocytes in the present study was carried out in culture dishes at 39 8C. The shift to higher incubation temperature results in the inactivation of the temperature-sensitive simian virus-40 large T antigen (tsSV40LT), allowing the cells to differentiate with the hormonal treatments. To demonstrate that MSF cells are converted into mature adipocytes under these conditions, cells grown to confluence at 32 8C were treated with the hormonal cocktail of glucocorticoids (troglitazone and hydrocortisone) and insulin and incubated at 39 8C. As control, a parallel set of cells grown at 39 8C in medium without the added hormones (regular medium, RM) was used. When cultured in the presence of the differentiation cocktail (designated DM) for 14 days, MSF cells underwent significant phenotypic changes with accompanying lipid accumulation (measured by Oil Red O staining), indicative of conversion to mature adipocytes, compared with those grown in RM ( (Fig. 2B ).
To determine whether incubation for 14 days constitutes an optimal period for MSF differentiation, Pparg expression at different time points (days 1, 8, and 14) during differentiation was evaluated by QPCR. Pparg transcripts were dramatically induced between days 8 and 14 of culture (Fig. 2C) , confirming maximal MSF conversion into mature adipocytes at day 14 ( Fig. 2A) . The transcript levels for the mammary adipogenic factor Il6 (Walter et al. 2009 ) similarly displayed modest but significant increases during this period (Fig. 2D) .
Soy isoflavone GEN dose dependently inhibits MSF differentiation to mature adipocytes
Given that dietary exposure to SPI and GEN is protective against mammary tumorigenesis in rodent models of breast cancer (Fritz et al. 1998 , Jin & MacDonald 2002 , Su et al. 2007b and that dietary exposure to GEN resulted in decreased mammary adipocyte size (Fig. 1A and B) , we evaluated whether mammary adipocytes constitute relevant direct targets of GEN for mammary tumor protection. MSF cells were grown to confluence and then differentiated with the addition of hormone cocktail in the presence or absence of physiologically relevant (40 nM) and supra-physiological (2 mM) levels of GEN (Rahal & Simmen 2010 , Montales et al. 2012 . As shown in Fig. 3A and B, the phenotypic formation of mature adipocytes (evaluated by Oil Red O staining) was significantly inhibited by 40 nM but not by 2 mM GEN. Expression of adipogenic and lipogenic genes was measured in control and GEN-treated (40 nM, 2 mM) cells after day 14 of culture ( Fig. 3C ). Pparg and Fasn gene expression in differentiated MSF cells were decreased by 40 nM GEN while GEN at 2 mM had no measurable effect on these genes' expression. Erb transcript levels were upregulated with 40 nM but not with 2 mM GEN treatment, while those for Era were unaffected by both GEN concentrations. Western blotting showed that GEN-treated mature adipocytes (40 nM GEN) had lower ERb protein levels than non-treated mature adipocytes in whole cell extracts ( Fig. 3D and E) , in contrast to the increased levels of corresponding transcript (Fig. 3C ).
GEN inhibition of adipocyte differentiation involves ERb signaling
ERb is known to exert anti-proliferative (Vivar et al. 2010) and anti-adipogenic (Foryst-Ludwig et al. 2008) effects. To further investigate whether GEN inhibition of adipogenesis is mediated solely by ERb signaling, we performed two studies. First, we determined whether the ERb-selective ligand DPN mimics the effects of GEN on adipocyte differentiation. MSF cells were cultured from confluence in DM with added GEN (40 nM), DPN (50 nM), or DMSO (vehicle control) and treated cells were evaluated for effects on adipocyte differentiation 14 days later. As shown earlier (Fig. 3) , GEN reduced adipocyte conversion of MSF cells (Fig. 4A) . DPN effects were less robust but paralleled the effects of GEN. Moreover, GEN and DPN comparably reduced lipid accumulation in mature adipocytes (Fig. 4B) . DPN showed no effects on Pparg and Fasn gene expression (Fig. 4C) . However, similar to GEN, DPN modestly increased (PZ0.06) Erb transcript, with coincident reduction in corresponding protein levels (Fig. 4D) . The protein levels of b-actin, as normalizing control, did not differ for DM or DMCDPN-treated cells (data not shown). In the second experiment, we evaluated the specificity of ERb effects on adipogenesis. MSF cells transfected with Erb siRNAs (and in parallel, non-targeting scrambled siRNAs for controls) were allowed to differentiate into mature adipocytes without or with added GEN (40 nM) and DPN (50 nM). MSF cells transfected with Erb siRNA showed dramatically decreased Erb transcript levels relative to those transfected only with scrambled siRNAs (Fig. 4E) . The increase (by 31%) in adipose conversion of MSF cells with Erb siRNAs targeting (relative to scRNA-treatment) (Fig. 4F ) was accompanied by a significant increase in Pparg gene expression but no effect on Fasn gene expression (Fig. 4G) . Co-treatment of MSFs with siErbC GEN decreased MSF conversion to adipocytes to the level of control (scRNA-treated) cells (Fig. 4F) . By contrast, adipose conversion of siErb-treated MSF cells was not affected by co-treatment with DPN (Fig. 4F) . potential effect of adipocyte CM on MCF-7 proliferation that may contribute to changes in mammosphere numbers, MCF-7 cells plated in culture dishes were treated with ACM or ACM (GEN) (diluted 1:1 (vol:vol) ratio with regular MCF-7 culture medium) and assayed for cell viability after 5 days. Adipocyte CM from vehicle-(DMSO) or GEN-treated adipocytes had no effect on MCF-7 cell viability (Fig. 5A) . By contrast, there were striking reductions in the number (Fig. 5B ) and size (diameter) (Fig. 5C and D) of mammospheres formed at passage 2 (P2) with ACM (GEN), relative to control ACM treatment. The cytokine IL6, which is synthesized by differentiated adipocytes (Fig. 2E) , has been shown to induce the expansion of mammary cancer stem/progenitor cells (Sansone et al. 2007 , Iliopoulos et al. 2011 . To determine whether GEN inhibits adipocyte-derived IL6 expression as a way to inhibit mammosphere formation, we evaluated IL6 transcript levels in GEN-treated adipocytes. Unlike for Pparg and Fasn (Fig. 3C) , GEN had no effect on Il6 transcript levels (data not shown). Moreover, IL6 at physiological levels (50 ng/ml) failed to promote mammosphere formation as well as to reverse the previously demonstrated inhibitory effects of 40 nM GEN (Montales et al. 2012 ) on mammosphere-forming ability of MCF-7 cells (Fig. 5E ).
Discussion
This study provides new mechanistic insights that may partly explain the favorable association of soy food intake with decreased breast cancer risk in the human population (Wu et al. 2008 , Hooper et al. 2010 and in rodent models of human breast cancer (Jin & MacDonald 2002 , Verheus et al. 2007 , Wu et al. 2008 . Using a recently characterized mouse MSF cell line that can differentiate into adipocytes with hormonal treatments, we provide evidence for the specificity of the antiadipogenic effect of the major soy isoflavone GEN on mammary adipose cells. Our findings based on in vivo (mice fed GEN diet) and in vitro (MSF conversion to mature adipocytes) models expand previously known effects of GEN on other anatomically distinct adipose depots, which have been correlated with its antitumor effects in relation to obesity's role in breast cancer development (Kim et al. 
Spiegelman 2000)
. Finally, we demonstrate that by inducing transcript levels for Erb, which has been shown to mediate inhibition of Pparg transcriptional activity and thus adipogenesis (Foryst-Ludwig et al. 2008) , GEN alters the trajectory of pre-adipocyte conversion to mature adipocytes. Our present findings of a direct influence of GEN on the adiposity of the mammary fat pad in vivo and in vitro, together with our previous demonstrations that GEN i) directly enhances mammary epithelial E-cadherinb-catenin interactions , ii) promotes mammary epithelial response to adiponectin (Rahal & Simmen 2011) , and iii) inhibits mammosphere expansion (Montales et al. 2012) , reveal how GEN (as a paradigm for bioactive dietary factors with antitumor effects) may simultaneously target two key mammary compartments (stroma and epithelium) that constitute obligate partners for breast cancer development and progression (Fig. 6 ).
Our aims in the present study were twofold. First, we wanted to mechanistically evaluate a direct role for GEN on mammary adipocyte differentiation, given our observations in rats ) that mammary adipocyte cell size is reduced with limited dietary exposure to SPI. Secondly, we sought to delineate how GEN effects on mammary adipocytes may translate to favorable effects on neighboring epithelial subpopulations from which tumors arise. While many bioactive components (Pabona et al. 2013) including other isoflavones are present in soy foods, GEN is considered to underlie the major antitumor effects associated with dietary soy intake, partly because it is bioavailable and targets diverse cell types (Verheus et al. 2007 , Xiao et al. 2008 , Rahal & Simmen 2011 . Our findings that GEN decreases mammary adipocyte cell size in vivo and inhibits MSF conversion to adipocytes in vitro, the latter resulting in repression of mammosphere formation of human breast cancer cells (a well-accepted surrogate for mammary tumorigenesis), identify GEN as a key mammary anti-adipogenic factor with significant potential for chemoprevention. Moreover, as the negative effect of limited dietary exposure to GEN on mammary adipocyte sizes did not occur simultaneously with observable changes in whole body weights, our results suggest that GEN-associated mammary anti-adipogenic effects in vivo may occur early and independent of its metabolic actions on other adipose depots (e.g. increasing systemic insulin sensitivity) for decreasing breast cancer risk. Studies utilizing diet-induced or genetically induced obese mouse models to delineate the temporal response of other fat depots in comparison to mammary adipose cells with dietary intake of GEN or of foods containing this isoflavone may help define the significance of GEN's context-specific anti-adipogenic effects for breast cancer prevention or chemoprevention.
Our findings highlight the participation of ERb signaling as a mediator of GEN's effects on adipocyte differentiation via a linear pathway involving GEN's induction of Erb expression and consequently of Pparg expression. While GEN displays a higher binding affinity (by 20-fold) for ERb than for ERa isoform (Kuiper et al. 1997) and likely exerts its actions by binding to this ER isoform, our findings suggest that ERb is not the sole mediator of GEN's inhibition of mammary adipocyte differentiation. We interpret GEN's reversal of siERb-induced adipocyte differentiation to indicate that GEN does not bind to ERb to mediate adipogenesis and/or that GEN induction of Erb expression overrides the effects of Erb knockdown under our experimental conditions. Our results showing that with Erb knockdown the selective ERb agonist DPN tended to inhibit adipocyte differentiation but not as robustly as GEN supports the latter possibility as DPN also increases ERb expression but not to the same extent as GEN. Moreover, the coincident upregulation of Pparg expression with Erb knockdown, in the absence of comparable effects on FASN, coupled with GEN's effects on FASN suggests that the robust effects of GEN on adipocyte differentiation may be attributed to GEN's cumulative inhibition of ERb-dependent Pparg gene expression and of ERb-independent Fasn gene expression. The latter suggests other likely mediators of GEN, which can function as a tyrosine kinase inhibitor (Akimoto et al. 2001 , Gadgeel et al. 2009 or via a G-protein-coupled ER (Lin et al. 2009 ).
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Figure 6
Postulated model for GEN control of mammary adipocyte differentiation. GEN influences ERb (increase; designated /), PPARg (decrease; designated by ), and FASN (decrease) gene expression to directly inhibit adipocyte differentiation and to indirectly repress the expansion of mammary cancer stem-like/progenitor cells (measured by mammosphere formation). This model incorporates our previous demonstration of a direct action of GEN on inhibiting mammosphere formation (Montales et al. 2012) . We had previously shown that in the mouse mammary epithelial cell line HC11, which expresses both ER isoforms, ERb-mediated GEN actions enhanced tumor suppressor PTEN expression (Rahal & Simmen 2011 ) and promoted membrane-bound E-cadherin interactions with b-catenin to attenuate oncogene Wnt1-stimulated cell proliferation ). Interestingly, while promotion of ERb signaling by GEN in HC11 mammary epithelial cells occurred without altering Erb transcription (Rahal & Simmen 2011) , GEN effects on inhibiting adipocyte differentiation involve induction of Erb transcript levels. Our findings of increased Erb transcript levels with 40 nM but not 2 mM GEN, coincident with decreased transcript levels for Pparg and Fasn, are consistent with a previous report that activation of ERb downregulates PPARg transcriptional activity at low (!1 mM) but not at high (O1 mM) GEN doses (Dang et al. 2002) . While we have no experimental data to address the observed discrepancy in ERb transcript and protein levels with GEN treatment leading to inhibition of adipocyte differentiation, we suggest that this may be related to increased ERb protein degradation and/or turnover upon ligand binding and induction of Erb transactivity, as previously reported for ERa. Transactivation of ERa requires estrogendependent receptor ubiquination and degradation (Lonard et al. 2000) . Moreover, the selective ERb ligand, DPN, elicited the same effects as GEN on ERb transcript and protein levels.
The present study evaluated the possibility that GEN by directly influencing mammary adipogenesis may indirectly modify epithelial behavior. We herein demonstrated that adipose-CM from mature adipocytes treated with GEN suppressed mammosphere formation of ERC MCF-7 cells, which have been previously shown to exhibit mammary tumor-initiating properties (Dontu et al. 2003 , Filmore & Kuperwasser 2008 . A relevant question raised by our findings relates to the identity of signaling molecule(s) mediating the observed inhibition of mammosphere-forming activity by adipose-CM from GEN-treated adipocytes. The composition of adipose-CM from control and GEN-treated adipocytes was not compared here and is thus considered a limitation of this study. Nevertheless, we considered IL6 as a candidate paracrine factor as its secretion from adipose stromal cells (Sansone et al. 2007 ) has been shown to promote migration and invasion of breast cancer cells (Walter et al. 2009 ). Moreover, IL6 has been implicated in breast cancer stem cell renewal as well as in the conversion of normal mammary stem cells to breast cancer stem cells (Iliopoulos et al. 2009 (Iliopoulos et al. , 2011 . Further, its expression increases in anatomically distinct fat depots (Bastard et al. 2000 , Hoene & Weigert 2008 during adipogenesis, consistent with our demonstration for the MSF cells (Fig. 2D ). However, GEN had no effect on IL6 expression in mammary adipocytes. Moreover, IL6 did not induce mammosphere formation and failed to reverse the inhibitory action of GEN on mammosphere-forming ability of MCF-7 cells. Thus, GEN's actions on mammary adipocytes and consequently on epithelial behavior are independent of IL6.
In summary, this study provides the first evidence to our knowledge of dietary factor regulation of MSF conversion to adipocytes and the potential consequence of this regulation on the functional expansion of mammary cancer stem-like/progenitor cells in vivo. This study suggests that by inhibiting 'local' adipogenesis in the mammary fat pad, dietary factors may have mammary tumor-preventative effects independent of their effects on body size or adiposity. Further, this study highlights the physiological importance of dietary factors in coordinating multiple local and systemic targets to generate the optimal 'niche' for mammary stem/progenitor cells so as to limit their expansion and subsequent tumor initiation. 
